MAP2K7 and liver cancer: In line with these results, LIPC protein level was found to be downregulated in the lung metastasis of liver cancer after treatment with everolimus, which was enhanced by trametinib supplement (Fig. 5f), indicating that mTOR and MEK inhibitors significantly repressed HCC lung metastasis.